Revised International Federation of Gynecology and Obstetrics (FIGO) staging systems in gynecologic malignancies.
10.5468/kjog.2010.53.8.669
- Author:
Maria LEE
1
;
Young Tae KIM
Author Information
1. Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea. ytkchoi@yuhs.ac
- Publication Type:Review
- Keywords:
FIGO;
Staging systems;
Gynecologic malignancies
- MeSH:
Cervix Uteri;
Endometrium;
Female;
Gynecology;
Humans;
Obstetrics;
Sarcoma;
Vulva
- From:Korean Journal of Obstetrics and Gynecology
2010;53(8):669-680
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The International Federation of Gynecology and Obstetrics (FIGO) has reported annually for the development and changes of gynecologic cancer classification and staging since 1958. FIGO staging systems in gynecologic malignancies has been reflected on prognostic factors in predicting patients' outcomes and organized patients into several groups. The aim of the FIGO staging system is to afford a classification of gynecologic cancer and to share treatment methods with others. The FIGO staging systems have been updated several times every 3 years according to the latest data, which is responsive and adaptive to scientific development including imaging and treatment modalities. In 2008, the FIGO staging system for carcinoma of the cervix, endometrium, vulva, and uterine sarcomas was revised. After applying the revised staging system in clinical setting, it is need to consider and review problems. As a result, we must make up for the weak points in staging systems continuously.
